Bionano Genomics (BNGO) Earnings Analysis
Bionano Genomics (BNGO) next reports earnings on 2026-08-13, consensus EPS -0.7 USD. Last quarter (2026-03-23) it beat with EPS -0.03 USD vs -0.81 USD est (+96.3%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -0.19.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BNGO next report earnings?
| Next earnings date | 2026-08-13 |
|---|---|
| Consensus EPS estimate | -0.7 USD |
| Revenue estimate | 0.01B |
BNGO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-23 | -0.03 USD | -0.81 USD | +96.3% | Beat |
| 2025-11-13 | -1.59 USD | -1.81 USD | +12.2% | Beat |
| 2025-08-14 | -1.99 USD | -2.69 USD | +26% | Beat |
| 2025-03-31 | -57.49 USD | -6 USD | -858.2% | Miss |
| 2024-11-14 | -19.16 USD | -0.21 USD | -9023.8% | Miss |
Beat rate: 3/5 (60%) over reported quarters with consensus data.
BNGO valuation and analyst view
| Trailing P/E | -0.19 |
|---|---|
| Trailing EPS | -5.80275 USD |
| Price / book | 0.16 |
| Dividend yield | 0.00% |
| Market cap | 0.01B |
| Analyst consensus | Buy (4 buy / 3 hold / 0 sell) |
Related research pages
Frequently asked questions
When is Bionano Genomics (BNGO)'s next earnings date?
Bionano Genomics is next scheduled to report on 2026-08-13, with a consensus EPS estimate of -0.7 USD and revenue estimate of 0.01B.
Did BNGO beat earnings last quarter?
In its 2026-03-23 report, BNGO posted EPS of -0.03 USD versus a -0.81 USD estimate — a beat of 96.3%.
What is BNGO's earnings track record?
Over the last 5 reported quarters with consensus data, BNGO beat estimates 3 times (60%).
What is BNGO's current P/E ratio and EPS?
BNGO trades at a trailing P/E of -0.19 on trailing EPS of -5.802754820936639 USD.
What do analysts rate BNGO?
Analyst consensus is "Buy" across 7 ratings (0 strong buy, 4 buy, 3 hold, 0 sell, 0 strong sell).